861 related articles for article (PubMed ID: 36355774)
1. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021.
Lewis HC; Ware H; Whelan M; Subissi L; Li Z; Ma X; Nardone A; Valenciano M; Cheng B; Noel K; Cao C; Yanes-Lane M; Herring BL; Talisuna A; Ngoy N; Balde T; Clifton D; Van Kerkhove MD; Buckeridge D; Bobrovitz N; Okeibunor J; Arora RK; Bergeri I;
BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35998978
[TBL] [Abstract][Full Text] [Related]
3. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
[TBL] [Abstract][Full Text] [Related]
4. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January-December 2020.
Vaughan A; Duffell E; Freidl GS; Lemos DS; Nardone A; Valenciano M; Subissi L; Bergeri I; K Broberg E; Penttinen P; Pebody R; Keramarou M
BMJ Open; 2023 Nov; 13(11):e064240. PubMed ID: 37931969
[TBL] [Abstract][Full Text] [Related]
6. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
[TBL] [Abstract][Full Text] [Related]
7. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.
Rostami A; Sepidarkish M; Leeflang MMG; Riahi SM; Nourollahpour Shiadeh M; Esfandyari S; Mokdad AH; Hotez PJ; Gasser RB
Clin Microbiol Infect; 2021 Mar; 27(3):331-340. PubMed ID: 33228974
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.
He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA
J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947
[TBL] [Abstract][Full Text] [Related]
11. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.
Jahan N; Brahma A; Kumar MS; Bagepally BS; Ponnaiah M; Bhatnagar T; Murhekar MV
Int J Infect Dis; 2022 Mar; 116():59-67. PubMed ID: 34968773
[TBL] [Abstract][Full Text] [Related]
14. Update on SARS-CoV-2 seroprevalence: regional and worldwide.
Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB
Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.
Liang Y; Sun Q; Liu Q; Pang Y; Tang S
Front Public Health; 2023; 11():1044788. PubMed ID: 37900041
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
[TBL] [Abstract][Full Text] [Related]
17. Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada.
Skowronski DM; Kaweski SE; Irvine MA; Kim S; Chuang ESY; Sabaiduc S; Fraser M; Reyes RC; Henry B; Levett PN; Petric M; Krajden M; Sekirov I
CMAJ; 2022 Dec; 194(47):E1599-E1609. PubMed ID: 36507788
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
Suntronwong N; Vichaiwattana P; Klinfueng S; Puenpa J; Kanokudom S; Assawakosri S; Chansaenroj J; Srimuan D; Thatsanatorn T; Songtaisarana S; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
PLoS One; 2023; 18(4):e0279147. PubMed ID: 37104299
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM
EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study.
Sapronova K; Kaķe R; Pavāre J; Grāvele D; Šēla I; Ērgle E; Isarova D; Grīnberga Z; Zavadska D
Medicine (Baltimore); 2023 Feb; 102(6):e32795. PubMed ID: 36820593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
